What the company does
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatment of brain cancer through photothermal and photodynamic therapies. It has a collaboration agreement with Olympus and ZEISS Medical Technologies for the development of FG001 for tumor imaging and surgical margins assessment for head and neck cancer. …
What the weekly tape is saying
FLUO closed the latest completed week at 44.10 SEK. The 4-week return is 3.8% and the 12-week return is 1.1%. Trend Signal is active, Market Dynamics is 0.98. Setup signature: Balanced read with a 51/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 38.15 SEK
- Vs Trend Line
- 15.6%
- Fair Value
- 49.85 SEK
- Vs Fair Value
- -11.5%
- 52W High
- 47.80 SEK
- 52W Low
- 28.00 SEK
- Drawdown
- -7.7%
- Range Position
- 81.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 5 weeks
- 52W Active Weeks
- 12
- 52W Active Breadth
- 23.1%
- Sector Scope
- SE Healthcare
- Sector Rank
- 112 of 158
- Sector Percentile
- 29.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 33 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Biotechnology
- Tracked Peers
- 59
- 4W Rank
- 18 of 59
- Avg 1W
- 3.1%
- Avg 4W
- -1.6%
- Trend Breadth
- 30.5%
- Positive RS
- 22.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.98
- 4W MD Change
- 15.8%
- Relative Strength
- 1.61
- 4W RS Change
- 251.9%
- Expectation
- Negative
- Probability
- 37.56%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 35.6K
- 13W Average
- 37.0K
- 52W Average
- 37.3K
- Vs 13W
- 1.0x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 12.9%
- 52W Volatility
- 8.3%
- Upside Weeks
- 25
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 6.2% / -5.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- SEK
- Market Cap
- 717.7M
Opportunity signals
- Trend Signal is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- Recent volatility is running well above the one-year baseline.
- Latest weekly return ranks in the weaker part of its sector group.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 44.10 SEK | -4.5% | 38.15 SEK | 49.85 SEK | 0.98 | 1.61 | 35.6K | On |
| 5 Jun 2026 | 46.20 SEK | 5.5% | 38.10 SEK | 50.11 SEK | 0.89 | 6.04 | 46.7K | On |
| 29 May 2026 | 43.80 SEK | 5.5% | 38.02 SEK | 50.38 SEK | 0.79 | -0.41 | 23.0K | On |
| 22 May 2026 | 41.50 SEK | -2.4% | 37.91 SEK | 50.64 SEK | 0.76 | -6.24 | 14.4K | On |
| 15 May 2026 | 42.50 SEK | -0.7% | 37.92 SEK | 50.92 SEK | 0.85 | -1.06 | 15.9K | On |
| 8 May 2026 | 42.80 SEK | 4.6% | 38.00 SEK | 51.22 SEK | 1.00 | -1.86 | 27.6K | Off |
| 1 May 2026 | 40.90 SEK | -4.4% | 38.04 SEK | 51.50 SEK | 0.98 | -6.11 | 26.9K | Off |
| 24 Apr 2026 | 42.80 SEK | 3.4% | 38.01 SEK | 51.83 SEK | 0.92 | -3.39 | 33.5K | Off |
| 17 Apr 2026 | 41.40 SEK | 7.0% | 37.87 SEK | 52.13 SEK | 0.86 | -9.24 | 64.2K | Off |
| 10 Apr 2026 | 38.70 SEK | 2.7% | 37.76 SEK | 52.41 SEK | 0.85 | -13.55 | 46.6K | Off |
| 3 Apr 2026 | 37.70 SEK | -0.8% | 37.86 SEK | 52.72 SEK | 0.39 | -12.34 | 21.5K | Off |
| 27 Mar 2026 | 38.00 SEK | -12.8% | 37.94 SEK | 53.10 SEK | 0.12 | -8.85 | 35.0K | Off |
| 20 Mar 2026 | 43.60 SEK | 44.4% | 38.02 SEK | 53.51 SEK | -0.09 | 4.31 | 90.1K | Off |
| 13 Mar 2026 | 30.20 SEK | -9.0% | 37.91 SEK | 53.88 SEK | -0.47 | -31.42 | 53.0K | Off |